BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ali SA, Mathur N, Malhotra AK, Braga RJ. Electroconvulsive Therapy and Schizophrenia: A Systematic Review. Mol Neuropsychiatry 2019;5:75-83. [PMID: 31192220 DOI: 10.1159/000497376] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Tsuboi T, Takaesu Y, Hasegawa N, Ochi S, Fukumoto K, Ohi K, Muraoka H, Okada T, Kodaka F, Igarashi S, Iida H, Kashiwagi H, Hori H, Ichihashi K, Ogasawara K, Hashimoto N, Iga JI, Nakamura T, Usami M, Nagasawa T, Kido M, Komatsu H, Yamagata H, Atake K, Furihata R, Kikuchi S, Horai T, Takeshima M, Hirano Y, Makinodan M, Matsumoto J, Miura K, Hishimoto A, Numata S, Yamada H, Yasui-Furukori N, Inada K, Watanabe K, Hashimoto R. Effects of electroconvulsive therapy on the use of anxiolytics and sleep medications: a propensity score-matched analysis. Psychiatry Clin Neurosci 2023;77:30-7. [PMID: 36215112 DOI: 10.1111/pcn.13489] [Reference Citation Analysis]
2 Kar SK, Menon V. Early augmentation by using neuromodulation in psychiatric disorder: a kaleidoscopic view. CNS Spectr 2022;27:530-2. [PMID: 33632361 DOI: 10.1017/S1092852921000237] [Reference Citation Analysis]
3 Bağcaz A, Başar K. Mirror-Image Comparison of Maintenance Electroconvulsive Treatment Effectiveness in Affective and Psychotic Disorders. J ECT 2022. [PMID: 35700971 DOI: 10.1097/YCT.0000000000000864] [Reference Citation Analysis]
4 Wada K, Kurata A, Iwamoto T, Gon J, Shimizu H. Oral theophylline augmentation for patients with missed or inadequate seizures with electroconvulsive therapy. Asian J Psychiatr 2022;73:103148. [PMID: 35597185 DOI: 10.1016/j.ajp.2022.103148] [Reference Citation Analysis]
5 Cheng YC, Kuo PH, Su MI, Huang WL. The efficacy of non-invasive, non-convulsive electrical neuromodulation on depression, anxiety and sleep disturbance: a systematic review and meta-analysis. Psychol Med 2022;52:801-12. [PMID: 35105413 DOI: 10.1017/S0033291721005560] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Schroeder AH, Bogie BJM, Rahman TT, Thérond A, Matheson H, Guimond S. Feasibility and Efficacy of Virtual Reality Interventions to Improve Psychosocial Functioning in Psychosis: Systematic Review. JMIR Ment Health 2022;9:e28502. [PMID: 35179501 DOI: 10.2196/28502] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Raymond N, Lizano P, Kelly S, Hegde R, Keedy S, Pearlson GD, Gershon ES, Clementz BA, Tamminga CA, Keshavan M. What can clozapine’s effect on neural oscillations tell us about its therapeutic effects? A scoping review and synthesis. Biomarkers in Neuropsychiatry 2022. [DOI: 10.1016/j.bionps.2022.100048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
8 Liu Y, Jia L, Wu H, Jiang W, Wang Q, Wang D, Xiong Y, Ren Y, Ma X, Tang Y. Adjuvant Electroconvulsive Therapy with Antipsychotics is Associated with Improvement in Auditory Mismatch Negativity in Schizophrenia. Psychiatry Research 2022. [DOI: 10.1016/j.psychres.2022.114484] [Reference Citation Analysis]
9 Hu Q, Huang H, Jiang Y, Jiao X, Zhou J, Tang Y, Zhang T, Sun J, Yao D, Luo C, Li C, Wang J. Temporoparietal Connectivity Within Default Mode Network Associates With Clinical Improvements in Schizophrenia Following Modified Electroconvulsive Therapy. Front Psychiatry 2021;12:768279. [PMID: 35058815 DOI: 10.3389/fpsyt.2021.768279] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Argyelan M, Lencz T, Kang S, Ali S, Masi PJ, Moyett E, Joanlanne A, Watson P, Sanghani S, Petrides G, Malhotra AK. ECT-induced cognitive side effects are associated with hippocampal enlargement. Transl Psychiatry 2021;11:516. [PMID: 34625534 DOI: 10.1038/s41398-021-01641-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
11 Shan X, Zhang H, Dong Z, Chen J, Liu F, Zhao J, Zhang H, Guo W. Increased subcortical region volume induced by electroconvulsive therapy in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 2021. [PMID: 34275006 DOI: 10.1007/s00406-021-01303-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Moon SY, Kim M, Lho SK, Oh S, Kim SH, Kwon JS. Systematic Review of the Neural Effect of Electroconvulsive Therapy in Patients with Schizophrenia: Hippocampus and Insula as the Key Regions of Modulation. Psychiatry Investig 2021;18:486-99. [PMID: 34218638 DOI: 10.30773/pi.2020.0438] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Garcia Ruiz PJ. Electroconvulsive Therapy and Movement Disorders. New Perspectives on A Time-Tested Therapy. Mov Disord Clin Pract 2021;8:521-4. [PMID: 33981784 DOI: 10.1002/mdc3.13180] [Reference Citation Analysis]
14 Moulier V, Krir MW, Dalmont M, Guillin O, Rothärmel M; SURECT Group. A prospective multicenter assessor-blinded randomized controlled study to compare the efficacy of short versus long protocols of electroconvulsive therapy as an augmentation strategy to clozapine in patients with ultra-resistant schizophrenia (SURECT study). Trials 2021;22:284. [PMID: 33858488 DOI: 10.1186/s13063-021-05227-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Alinejad Machiani S, Namdar Areshtanab H, Ebrahimi H, Sarbakhsh P, Noorazar SG, Goljarian S. The Effect of Foot Reflexology on Amnesia in Patients Undergoing Electroconvulsive Therapy: A Randomized Clinical Trial. J Caring Sci 2021;10:15-21. [PMID: 33816380 DOI: 10.34172/jcs.2021.004] [Reference Citation Analysis]
16 Plahouras JE, Konstantinou G, Kaster TS, Buchman DZ, Foussias G, Daskalakis ZJ, Blumberger DM. Treatment Capacity and Clinical Outcomes for Patients With Schizophrenia Who Were Treated With Electroconvulsive Therapy: A Retrospective Cohort Study. Schizophr Bull 2021;47:424-32. [PMID: 33145601 DOI: 10.1093/schbul/sbaa144] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Češková E, Hýža M. Treatment possibilities of pharmaco-resistant schizofrenie in common clinical practice. Psychiatr pro Praxi 2020;21:78-82. [DOI: 10.36290/psy.2020.014] [Reference Citation Analysis]
18 Kar SK, Singh A, Prakash AJ. Neuromodulation in Schizophrenia: Relevance of Neuroimaging. Curr Behav Neurosci Rep 2020;7:139-46. [DOI: 10.1007/s40473-020-00209-2] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Usta Saglam NG, Aksoy Poyraz C, Yalcin M, Balcioglu I. ECT augmentation of antipsychotics in severely ill schizophrenia: a naturalistic, observational study. Int J Psychiatry Clin Pract 2020;24:392-7. [PMID: 32538214 DOI: 10.1080/13651501.2020.1777313] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
20 Zhuo C, Xu X, Lin X, Chen M, Ji F, Jiang D, Xu Y, Wang L, Li Y, Tian H, Wang W, Zhou C. Depressive symptoms combined with auditory hallucinations are accompanied with severe gray matter brain impairments in patients with first-episode untreated schizophrenia - A pilot study in China. Neurosci Lett 2020;730:135033. [PMID: 32417389 DOI: 10.1016/j.neulet.2020.135033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Ceskova E. Pharmacological strategies for the management of comorbid depression and schizophrenia. Expert Opinion on Pharmacotherapy 2020;21:459-65. [DOI: 10.1080/14656566.2020.1717466] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Jia J, Shen J, Liu FH, Wong HK, Yang XJ, Wu QJ, Zhang H, Wang HN, Tan QR, Zhang ZJ. Effectiveness of Electroacupuncture and Electroconvulsive Therapy as Additional Treatment in Hospitalized Patients With Schizophrenia: A Retrospective Controlled Study. Front Psychol 2019;10:2306. [PMID: 31681100 DOI: 10.3389/fpsyg.2019.02306] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]